367 related articles for article (PubMed ID: 14634213)
1. P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1.
Asher G; Lotem J; Tsvetkov P; Reiss V; Sachs L; Shaul Y
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15065-70. PubMed ID: 14634213
[TBL] [Abstract][Full Text] [Related]
2. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin.
Tsvetkov P; Asher G; Reiss V; Shaul Y; Sachs L; Lotem J
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5535-40. PubMed ID: 15809436
[TBL] [Abstract][Full Text] [Related]
4. The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol.
Asher G; Dym O; Tsvetkov P; Adler J; Shaul Y
Biochemistry; 2006 May; 45(20):6372-8. PubMed ID: 16700548
[TBL] [Abstract][Full Text] [Related]
5. 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1.
Asher G; Bercovich Z; Tsvetkov P; Shaul Y; Kahana C
Mol Cell; 2005 Mar; 17(5):645-55. PubMed ID: 15749015
[TBL] [Abstract][Full Text] [Related]
6. NQO1 stabilizes p53 through a distinct pathway.
Asher G; Lotem J; Kama R; Sachs L; Shaul Y
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3099-104. PubMed ID: 11867746
[TBL] [Abstract][Full Text] [Related]
7. NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53.
Gong X; Kole L; Iskander K; Jaiswal AK
Cancer Res; 2007 Jun; 67(11):5380-8. PubMed ID: 17545619
[TBL] [Abstract][Full Text] [Related]
8. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.
Rodriguez MS; Desterro JM; Lain S; Lane DP; Hay RT
Mol Cell Biol; 2000 Nov; 20(22):8458-67. PubMed ID: 11046142
[TBL] [Abstract][Full Text] [Related]
9. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73.
Asher G; Tsvetkov P; Kahana C; Shaul Y
Genes Dev; 2005 Feb; 19(3):316-21. PubMed ID: 15687255
[TBL] [Abstract][Full Text] [Related]
10. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1.
Asher G; Lotem J; Cohen B; Sachs L; Shaul Y
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1188-93. PubMed ID: 11158615
[TBL] [Abstract][Full Text] [Related]
11. DNA damage-induced MDMX degradation is mediated by MDM2.
Kawai H; Wiederschain D; Kitao H; Stuart J; Tsai KK; Yuan ZM
J Biol Chem; 2003 Nov; 278(46):45946-53. PubMed ID: 12963717
[TBL] [Abstract][Full Text] [Related]
12. MDM2 can promote the ubiquitination, nuclear export, and degradation of p53 in the absence of direct binding.
Inoue T; Geyer RK; Howard D; Yu ZK; Maki CG
J Biol Chem; 2001 Nov; 276(48):45255-60. PubMed ID: 11572869
[TBL] [Abstract][Full Text] [Related]
13. p53 proteasomal degradation: poly-ubiquitination is not the whole story.
Asher G; Shaul Y
Cell Cycle; 2005 Aug; 4(8):1015-8. PubMed ID: 16082197
[TBL] [Abstract][Full Text] [Related]
14. Dicoumarol sensitizes renal cell carcinoma Caki cells to TRAIL-induced apoptosis through down-regulation of Bcl-2, Mcl-1 and c-FLIP in a NQO1-independent manner.
Park EJ; Min KJ; Choi KS; Kwon TK
Exp Cell Res; 2014 Apr; 323(1):144-154. PubMed ID: 24462458
[TBL] [Abstract][Full Text] [Related]
15. Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.
Buranrat B; Prawan A; Kukongviriyapan U; Kongpetch S; Kukongviriyapan V
World J Gastroenterol; 2010 May; 16(19):2362-70. PubMed ID: 20480521
[TBL] [Abstract][Full Text] [Related]
16. MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts.
Gentiletti F; Mancini F; D'Angelo M; Sacchi A; Pontecorvi A; Jochemsen AG; Moretti F
Oncogene; 2002 Jan; 21(6):867-77. PubMed ID: 11840332
[TBL] [Abstract][Full Text] [Related]
17. Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells.
Ahn HJ; Kim KS; Shin KW; Lim KH; Kim JO; Lee JY; Kim J; Park JH; Yang KM; Baek KH; Ko JJ; Park KS
Oncotarget; 2015 Dec; 6(42):44523-37. PubMed ID: 26540344
[TBL] [Abstract][Full Text] [Related]
18. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation.
Jin Y; Lee H; Zeng SX; Dai MS; Lu H
EMBO J; 2003 Dec; 22(23):6365-77. PubMed ID: 14633995
[TBL] [Abstract][Full Text] [Related]
19. Negative Cooperativity in NAD(P)H Quinone Oxidoreductase 1 (NQO1).
Megarity CF; Abdel-Aal Bettley H; Caraher MC; Scott KA; Whitehead RC; Jowitt TA; Gutierrez A; Bryce RA; Nolan KA; Stratford IJ; Timson DJ
Chembiochem; 2019 Nov; 20(22):2841-2849. PubMed ID: 31165578
[TBL] [Abstract][Full Text] [Related]
20. Stability and ubiquitination of the tumor suppressor protein p53.
Jardine LJ; Maki CG
Methods Mol Biol; 2003; 223():27-38. PubMed ID: 12777718
[No Abstract] [Full Text] [Related]
[Next] [New Search]
